Brenton Scott
Gründer bei Pulmotect, Inc.
Vermögen: 5 Mio $ am 30.04.2024
Profil
Brenton Scott has founded two companies, Bondwell Technologies, Inc. in 2017 and Pulmotect, Inc. in 2007, where he holds the title of President & Chief Operating Officer.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
13.02.2023 | 21 185 283 ( 25,41% ) | 5 Mio $ | 30.04.2024 |
Aktive Positionen von Brenton Scott
Unternehmen | Position | Beginn |
---|---|---|
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Gründer | 01.01.2007 |
Ehemalige bekannte Positionen von Brenton Scott
Unternehmen | Position | Ende |
---|---|---|
Bondwell Technologies, Inc.
Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Pulmotect, Inc.
Pulmotect, Inc. BiotechnologyHealth Technology Pulmotect, Inc. develops clinical stage, novel, pathogen-agnostic, inhaled compound for the prevention and early treatment of acute, severe viral and bacterial respiratory infections. It provides safe, broad-spectrum, fast-acting protection against bacterial pneumonia (including MRSA), influenza, fungal pneumonia, and Class A bioterror agents (including anthrax, tularemia, and plague). The company was founded by Brenton Scott and Magnus Hook in 2007 and is headquartered in Houston, TX. | Health Technology |
Bondwell Technologies, Inc.
Bondwell Technologies, Inc. BiotechnologyHealth Technology Bondwell Technologies, Inc. engages in the development of biomaterial-based platform technology. It helps utilize the natural ability of proteins, molecular tools required for every natural process. The company was founded by Brenton Scott, David Howell, Sarah E. Bondos, and Kristin A. Howell on August 7, 2017 and is headquartered in College Station, TX. | Health Technology |